Melanie Schwerdtfeger

Melanie Schwerdtfeger is a skilled scientist currently employed at Coriolis Pharma since December 2021. Prior to this role, Melanie Schwerdtfeger completed a PhD from the University of Campania "Luigi Vanvitelli" in the lab of Professor Vincenzo Desiderio, which lasted from November 2018 to October 2021. Earlier academic experiences include a Master's thesis on virus-like vaccines against HIV/SIV at Københavns Universitet under Professor Peter Holst and an internship focused on histone chaperone Daxx at the University of Wisconsin-Madison in Professor Peter Lewis's lab. Additionally, Melanie Schwerdtfeger holds a Bachelor of Science and a Master of Science in Molecular Medicine from the University of Regensburg, with a bachelor thesis conducted under the guidance of PD Dr. Dr.